Daily Stock List
Elite Pharmaceuticals, Inc. (ELTP)
Real Pennies reported last week on Elite Pharmaceuticals, Inc. (ELTP), SmarTrend Newsletters, GoldminePennyStocks, Greenbackers, PennyTrader Publisher did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical enterprise. Their commitment is to developing and commercializing oral controlled release product formulations and the manufacturing of generic pharmaceuticals. The Company has four commercial products, with five additional products under review, pending approval by the Food and Drug Administration (FDA). Elite Pharmaceuticals operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, New Jersey. The Company's shares trade on the OTC Bulletin Board.
Elite's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry. Their lead pipeline products include abuse resistant opioids utilizing their patented proprietary technology, and a once-daily opioid. In addition, Elite Pharmaceuticals has collaborated with Mikah Pharma to develop a new product, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the U.S. market and its territories.
In mid-November 2012, Elite Pharmaceuticals announced the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic equivalent of Bontril PDM® 35 mg tablets under the previously announced manufacturing and supply agreement with Mikah Pharma. Actavis, Inc., recently acquired by Watson Pharmaceuticals, Inc., will distribute the product as part of a distribution agreement between Mikah and Actavis. Elite will receive compensation at an agreed upon price for the manufacturing and packaging of the product.
Last month, Elite announced that they have in place an agreement for the next year with the Company's sole supplier of the active pharmaceutical ingredient (API) for Elite's Phentermine product lines. These include Phentermine HCl tablets 37.5 mg. and Phentermine HCl capsules 15 mg. and 30 mg. Elite disclosed a supply limitation on October 15, 2012, but this is now resolved for the next year.
Elite Pharmaceuticals, Inc. (ELTP), closed Tuesday's trading session at $0.0755, up 4.14%, on 3,535,640 volume with 133 trades. The average volume for the last 60 days is 1,958,939 and the stock's 52-week low/high is $0.0507/$0.174.
Zippy Bags, Inc. (ZPPB)
OTCPicks, Premium Stock Picks, PennyStockNewsletter.info, and Information Solutions Group reported earlier on Zippy Bags, Inc. (ZPPB), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Zippy Bags, Inc. is a specialty hybrid sporting goods bag manufacturing company based in Salt Lake City, Utah. The Company manufactures hybrid bike and snowboard protective enclosures. They feature innovative multi-functional products with creative designs. Zippy Bags was originally conceived in the heart of high altitude bicycling and snowboarding in the Utah Rocky Mountains.
The Company's products include the Zippy Bike Bag, the Zippy Snowboard Bag, and the Zippy Wheel Bag. Formed in the State of Nevada on August 26, 2010, the Company lists on the OTCBB.
Zippy Bags corporate mission is to be the leader in offering innovative, premium crafted hybrid protective gear. All of their products are hand crafted in the United States. The Company is quickly growing and becoming recognized in the snowboarding and bicycling accessory industries. Zippy Bags has received positive input from the automobile racing industry for their helmet and racing gear combo-bag. Specific emphasis will be on FIA-Formula One and NASCAR as target markets. The Zippy Racing Bag is a convenient and distinctive package. The bag is completely expandable to meet the driver's needs on any given basis. It can carry a racing helmet and a racing suit, gloves, and more.
The Company's intention is to market Zippy through a combination of direct sales, referrals and networking within the industry. This year, Zippy Bags plans to build out their reputation, develop a network in the snowboard carrying bags business, and begin sales to the public. The Company has established an internet website (www.zippybagsinc.com) where customers can purchase the snowboard carrying bag.
Today, Zippy Bags announced that they secured a new sales agreement for 12,000 Zippy Bike Bags with World Wide Wholesale, Inc. This sales agreement will further assist in the worldwide expansion of the Company's entire product line.
Chief Executive Officer, Janet Somsen, said, "With the ongoing trends and continued sustainable growth of the bicycling industry in the European markets, we are greatly concentrating our sales and marketing efforts on the countries of France, Germany, Italy and Spain as our initial foreign markets. We have forecasted a major growth pattern of our company's sales in these countries. Europe has a devout following and customer participation of the entire bicycling industry. Zippy Bike Bag is a perfect fit that meets the needs and lifestyle of these enthusiasts. World Wide Wholesale, Inc. sees how our product lines and brand can meet those needs for the end user and we are extremely excited about this working relationship."
Zippy Bags, Inc. (ZPPB), closed Tuesday's trading session at $0.2861, up 217.89%, on 14,429,456 volume with 2,184 trades. The average volume for the last 60 days is 5,106 and the stock's 52-week low/high is $0.09/$5.00.
Derycz Scientific, Inc. (DYSC)
IRGnews Alert, FeedBlitz, and OTC Journal reported previously on Derycz Scientific, Inc. (DYSC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Encino, California, Derycz Scientific, Inc. is an information logistics company that lists on the OTC Bulletin Board. The Company and their subsidiaries develop products, services and systems to facilitate the re-use of published content in a way that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Their subsidiary companies include Reprints Desk, Inc., and Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG).
Derycz Scientific and their subsidiaries develop enterprise information logistics solutions for Fortune 500 companies in the life sciences and other research-intensive industries. They also have customers in the food and agriculture, petroleum, chemicals, legal, and academia sectors.
Derycz provides services, including document delivery, reprints and eprints, and printing and reprint management. The Company offers Internet-based interfaces that enable customers to initiate orders and manage transactions, by specifying the citation or other identifying information related to the particular article they need.
In addition, the Company prints the copies of published materials of marketing departments that undergo distribution to interested parties, including customers and doctors who prescribe a customer's product. Derycz also prints other materials that are used for marketing purposes and provides other printing logistics products and services.
Derycz Scientific's publisher solutions include technology solutions and reprint management services that eliminate the need for the publishers to establish a dedicated reprints sales force or arrange for delivery of reprinted materials. Derycz's eprint software systems enable publishers to protect their copyrighted content and support the marketing needs of their customers.
Last month, Derycz Scientific announced that their wholly owned subsidiary, Reprints Desk, ranked first in overall satisfaction and in each customer satisfaction category in the Document Delivery: Best Practices and Vendor Scorecard – 2012 Update, published by media, information and technology analyst and research advisory firm Outsell, Inc. Outsell is the world's only research and advisory firm focusing solely on media, information and technology.
Derycz Scientific, Inc. (DYSC), closed Tuesday's trading session at $1.00, up 4.17%, on 7,283 volume with 8 trades. The average volume for the last 60 days is 9,725 and the stock's 52-week low/high is $0.65/$1.49.
Kennady Diamonds, Inc. (KDI.V)
Today we are highlighting Kennady Diamonds, Inc. (KDI.V), here at the QualityStocks Daily Newsletter.
Kennady Diamonds, Inc. is a leading diamond exploration company whose shares trade on the TSX Venture Exchange. Their exploration focus is on 13 leases and claims (100 percent controlled), located immediately adjacent to the De Beers/Mountain Province Diamonds joint venture property in the Northwest Territories (NT), Canada. Kennady Diamonds controls 100 percent of the Kennady North project. The Company has their corporate headquarters in Toronto, Ontario
The Kennady North Project is 280 kilometers east-northeast of Yellowknife, NT in the District of Mackenzie. The property consists of five mineral leases and eight mineral claims totaling 30,532 acres, or 12,356 hectares. The project covers an area approximately 20 kilometers long and 15 kilometers wide.
Exploration at Kennady North began in the late 1990's. It resulted in the discovery of the diamond-bearing Kelvin, Faraday and Hobbes kimberlites. Exploration samples from Kelvin and Faraday returned a relatively large number of macro diamonds with the two largest being a 0.4 carat diamond from Faraday and a 0.09 carat diamond from Kelvin.
Exploration at Kennady North began again in 2011 with a 50-meter line-spacing airborne gravity gradiometry (AGG) survey over the entire 123.6 square kilometer project area. The survey identified 106 geophysical targets. Mountain Province has completed a 560-line-kilometer total magnetic field (MAG) ground survey over all 106 geophysical targets identified by the AGG survey. The 39 high priority targets identified through the AGG and MAG surveys underwent testing as part of the 2012 summer drill program and will undergo testing as part of the 2013 winter drill program (approximately 20 drill targets).
In November 2012, Kennady Diamonds announced the closing of the previously announced non-brokered private placement of flow-through and non flow-through common shares, for aggregate gross proceeds of $3,000,000.00. The shares are subject to a four-month hold period, expiring March 8, 2013. Kennady will use the proceeds of the private placement primarily for the Company's planned 5,000-meter winter drill program at the Kennady North diamond project, which is expected to begin in March 2013. They will also use the proceeds for working capital.
Kennady Diamonds, Inc. (KDI.V), closed Tuesday's trading session at $1.27, up 0.79%, on 24,180 volume. The stock's 52-week low/high is $0.98/$1.80.
Northumberland Resources, Inc. (NHUR)
We are highlighting Northumberland Resources, Inc. (NHUR) today, here at the QualityStocks Daily Newsletter.
Based in Las Vegas, Nevada, Northumberland Resources, Inc. engages in the business of precious minerals exploration and oil and gas exploration and production. Incorporated in the State of Nevada on June 22, 2009, their plan of operations is to further develop their oil and gas acquisitions in Kansas and carry out further exploration and acquisition in the oil and gas sectors. The Company has upgraded the facilities on their acquired Mason, Thompson, Keyes and Harrell Sanders, Asmussen and Carver leases with the goal of improving current oil and gas production.
Northumberland Resources' oil and gas projects are in the Mississippi Lime region in southern Kansas. The Company's management has acquired 11 leases covering 1840 acres with 27 oil and gas well sites. Northumberland commenced production in 2011.
Northumberland had revenues of $87,594 during the three months ended September 30, 2012, compared to $43,781 in revenues during the same period in 2011. Revenues were from oil and gas production occurring at previously purchased property sites. The Company incurred a net loss of $159,747 during the three months ended September 30, 2012, in comparison to a net loss of $213,863 during the same period in 2011. This translates to a loss per share of $0.00 and $0.00 for the three months ended September 30, 2012 and 2011, respectively.
They had revenues of $367,744 during the nine months ended September 30, 2012, compared to $43,781 revenues during the corresponding period in 2011. The Company had a net loss of $516,997 during the nine months ended September 30, 2012, compared to a net loss of $387,998 during the corresponding period in 2011. This translates to a loss per share of $0.00 and $0.00 for the nine months ended September 30, 2012 and 2011, respectively.
At the end of October 2012, Northumberland Resources announced that they received and accepted an offer to purchase 100 percent of their 30 percent working interest in their Lester lease, 15 percent interest in their Miller lease and 20 percent interest in their Moon leases for $384,686 as part of their 2013 expansion plans.
They will use the funds to expand the current oil production on their 5 lease Sawyer oil and gas field, develop current leases and acquire additional proven producing properties. Additionally, the Company will be participating in new production drilling on their current interests on the Carver, Asmussen and Holt leases.
Northumberland Resources, Inc. (NHUR), closed Tuesday's trading session at $0.56, up 1.82%, on 2,500 volume with 1 trade. The average volume for the last 60 days is 2,833 and the stock's 52-week low/high is $0.52/$0.56.
Wall Street Resources and SmallCapVoice reported earlier on Point.360 (PTSX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Los Angeles, California, Point.360 is a full-service audio-visual asset management and distribution company. The Company is a value added service organization specializing in content creation, manipulation and distribution processes integrating complex technologies to solve problems in the life cycle of Rich Media. Their interconnected facilities provide service coverage to all major U.S. media centers. Point.360 also rents and sells DVDs and video games directly to consumers through their Movie>Q retail stores. The Company lists on the NASDAQ Capital Market.
The Company has been serving the studios and independents in postproduction for more than 30 years. They provide creative, high-end results for television series, feature films, commercials, restoration, and corporate content. Point.360 handles Feature and Episodic VFX, Editorial, Color Correction, Audio, Animation, Graphics and Title Creation, Closed Captioning & Subtitling, Digital Intermediates, Film Scanning, Global Delivery, Encoding & Transcoding, Duplication, Conversions, and more.
Point.360's customers include independent motion picture and television production companies, television program suppliers, national television networks, local television stations, television program syndicators, corporations, educational institutions, and corporate or instructional video providers.
This past November, Point.360 announced results for the three-month period ended September 30, 2012 (First Fiscal Quarter Results). For the quarter, their sales were $7.7 million generating positive operating cash flow of $0.3 million and earnings before interest, taxes, depreciation and amortization and non-cash charges (EBITDAN) of $0.8 million for the period. This revenue of $7.7 million is in comparison to $9.0 million in the same quarter a year prior.
In the first quarter of fiscal 2013, gross margin was $2.7 million (35 percent of sales), compared to $3.4 million (38 percent of sales) in the prior year's first quarter. Operating income was $0.2 million in the first quarter of fiscal 2013 compared to a $0.3 million profit in the prior year's first quarter. For the first quarter of fiscal 2013, Point.360 reported a net loss of $0.1 million ($0.01 per share) in comparison to a net income of $0.1 million ($0.01 per share) in the same period the year prior.
Point.360 (PTSX), closed Tuesday's trading session at $0.7872, up 14.09%, on 5,290 volume with 8 trades. The average volume for the last 60 days is 7,955 and the stock's 52-week low/high is $0.50/$1.57.
Katanga Mining Ltd. (KAT.TO)
Today's Financial News reported previously on Katanga Mining Ltd. (KAT.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Incorporated in 1996, Katanga Mining Ltd. operates a major mine complex in the Democratic Republic of Congo (DRC), producing refined copper and cobalt. This is a large-scale copper-cobalt project with substantial high-grade mineral reserves and integrated metallurgical operations. The Company holds a 75 percent stake in two joint ventures with Gécamines, a state-owned mining company in the DRC. Katanga Mining's shares trade on the Toronto Stock Exchange; the Company is based in Zug, Switzerland and they have a South Africa office in Longmeadow.
Katanga Mining operates a large-scale copper-cobalt mine complex in the DRC through two joint ventures, Kamoto Copper Company (KCC) and DRC Copper and Cobalt Project (DCP). KCC and DCP operate on adjacent properties in the DRC and are working to create a major single-site copper and cobalt operation. With an amended joint venture agreement signed in July 2009, KCC and DCP will merge.
KCC and DCP engage in the exploration, refurbishment and rehabilitation of the Kamoto/Dima mining complex (the Kamoto Project) and the KOV copper and cobalt mine, respectively in the DRC. The Kamoto Project includes exploration and mining properties, the Kamoto concentrator, the Luilu metallurgical plant, the Kamoto underground mine, as well as two oxide open pit resources in the Kolwezi district of the DRC. Furthermore, Katanga additionally has several other mines and plants that may be operated initially or at a later stage in the Company's development. These include the open pit mines Mashamba East, Musonoie-T17 and Kananga.
Recently, Katanga Mining announced the first copper production through the new solvent extraction plant and converted electro-winning facility. They announced the successful production of the first copper cathodes from the newly commissioned facilities as part of the Updated Phase 4 Expansion program. The new facilities include the first Solvent Extraction (SX) train with an annual capacity of 100,000 tonnes of copper and the first 144 Electro-Winning (EW) cells with an annual capacity of 40,000 tonnes of copper.
The Updated Phase 4 project began in Q3/2011. It will enable Katanga Mining to increase total processing capacity and upgrade the quality of copper produced through the application of modern technologies and processes. Mechanical completion of the Updated Phase 4 Expansion is expected in the third quarter of 2013.
Katanga Mining Ltd. (KAT.TO), closed Tuesday's trading session at $0.73, up 1.39%, on 27,600 volume. The stock's 52-week low/high is $0.41/$1.32.
Dethrone Royalty Holdings, Inc. (DRHC)
Penny Stocks VIP reported today on Dethrone Royalty Holdings, Inc. (DRHC), News Desk did recently, and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Dethrone Royalty Holdings, Inc., via their wholly owned subsidiary, Dethrone Beverage, Inc., engages in the manufacture and sale of sports performance or energy drinks, and other non-alcoholic beverages under the Dethrone Beverages trade name in the U.S. Dethrone™ was carefully formulated to support mental focus and help increase blood flow, giving the body the fuel necessary to function through the day.
The Company formerly went by the name Exclusive Building Services, Inc. They changed their name to Dethrone Royalty Holdings, Inc. in September of 2012. Founded in 1997, Dethrone Royalty Holdings has their headquarters in Cave Creek, Arizona. The Company's shares trade on the OTC Bulletin Board.
Dethrone Royalty has been an important factor in the growth of the Mixed Martial Arts (MMA) sports field. The Dethrone Royalty brand formed in 2009 and its basis is on the traditions of ancient kings. Mr. Nick Swinmurn is behind the success of Dethrone Royalty. He was Founder of Zappos.com and is part owner of the NBA team the Golden State Warriors.
The design of Dethrone's innovative blends are to bridge the gap between energy drinks such as Monster™, nutritional supplements, and hydration drinks like Gatorade™ - without negative effects. Dethrone will launch on the U.S. west coast with Tier One (major beer distributors), and be in chains such as 7-11, Nugget Markets, and C-Stores like AM PM, Circle K and Quik Trip.
The Company is broadening their appeal beyond the world of Mixed Martial Arts (MMA) and the UFC (Ultimate Fighting Championship) through entering into Endorsement deals with superstar athletes from the NFL, MLB, NHL and NBA. They are also sponsoring major sporting events and social causes.
Yesterday, Dethrone Royalty Holdings announced that they signed an Agreement with Overtime Sports and Marketing, LLC, the Owners of the Texas vs. the Nation, to be title sponsor of this year's Texas vs. the Nation All-Star Challenge to take place at Allen Eagle Stadium in Allen, Texas on February 2, 2013 and broadcast nationally on FOX Sports. Texas vs. the Nation serves as a platform for professional scouts to evaluate prospects for the NFL and other pro football leagues.
The sponsorship package for the event includes several thirty-second TV Spots, several verbal mentions during the broadcast of the game, inclusion in all TV advertisements, and several Jumbotron ads and radio public service announcements, among other items.
Dethrone Royalty Holdings, Inc. (DRHC), closed Tuesday's trading session at $0.12, down 22.58%, on 2,388,547 volume with 309 trades. The average volume for the last 60 days is 55,082 and the stock's 52-week low/high is $0.055/$1.50.
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.097, off by 3.00%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 56,574, and its 52-week low/high is $0.0069/$0.13.
Viscount Systems, Inc. reported reception of several orders today for their iron-clad, IT-based physical security systems for a set of new high-rise condos projects in Montreal. President and CEO of VSYS, Stephen Pineau, noted the considerable upsurge in the traditional multi-residential business segment of late and explained that while flagging housing starts impacted overall revenue performance during the last two years, recovery in new construction projects, combined with upticks in government, education, and broader commercial segments, are making the 2013-2014 top line revenue projections look solid.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Systems To Secure Canadian Hotel Chain
Viscount Awarded Contract to Secure New Mexico School District
Viscountís Freedom Security Software Installed at Additional U.S. Government Facilities
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0125, up 25.00%, on 12,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 135,826, and its 52-week low/high is $0.001/$0.02.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.053, up 5.58%, on 7,084,697 volume with 233 trades. The stock’s average daily volume over the past 60 days is 2,860,801, and its 52-week low/high is $0.0275/$0.179.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis to Present at the 6th Annual OneMedForum
Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer
Advaxis Receives Preliminary Approval for Sale of Losses from State of NJ Economic Development Authority
The Guitammer Company Inc. (GTMM)
The QualityStocks Daily Newsletter would like to spotlight The Guitammer Company Inc. (GTMM). Today, The Guitammer Company Inc. closed trading at $0.16, up 6.67%, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 13,484, and its 52-week low/high is $0.082/$0.35.
The Guitammer Company Inc. (GTMM) is a leader in low-frequency sound products and technology. The company’s award-winning line of patented ButtKicker brand audio transducers let users actually feel the excitement, impacts, special effects, and bone-rattling bass brought by its immersive “4D” patent-protected technology. Guitammer’s products are well known for being musically accurate, powerful, and virtually indestructible.
The Guitammer Company was founded in 1990 by Ken McCaw, an accomplished musician, composer, and producer. Joining forces with Marvin Clamme, former sound engineer for Tom Jones and Merle Haggard, Ken and Marvin developed the original ButtKicker transducer prototypes in 1994.
Today, the ButtKicker brand products are used around the world by leading entertainment and theater companies, including AMC, IMAX, and Disney, in movie theaters and attractions. 85 entertainment locations in 11 countries have incorporated ButtKicker products to-date, providing the ultimate experience to over 10,000 seats. The products are also used in home theaters, simulators, and car audio applications.
Guitammer’s technology is compatible to virtually any digital source, including cable, satellite, fiber optic, IPTV, “over-the-air” broadcast, video games, and audio CDs. The ButtKicker brand products add unparalleled realism and excitement to movies, music, and games. Guitammer’s low-frequency, high-impact sound innovation is the next logical step after HDTV, 3DTV, and TiVo, bringing ground-breaking changes in how consumers enjoy their entertainment. Disclaimer
The Guitammer Company Inc. Company Blog
The Guitammer Company Inc. News:
Guitammer Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
Guitammer Third Quarter Revenue More Than Triples To $555,000
Guitammer CEO Mark Luden to Present at 7th Annual Singular Research 'Best of the Uncovereds' Conference in Los Angeles
Viscount Systems, a leading-edge supplier of security systems and software, announced this morning that it has received orders to secure a number of new high-rise condominiums projects in Montreal, Canada. The systems to be installed include Freedom access control as well as Viscount’s new 32” building information kiosks and visitor entry systems.
“We are beginning to see an upsurge in our traditional multi-residential business,” stated Stephen Pineau, President and CEO of Viscount. “Since our traditional business was heavily new construction oriented the low housing starts of the last two years had impacted our revenues just as we began to release Freedom. The recovery in new construction projects coupled with increasing sales of Freedom to the government, educational, and commercial sectors creates a very positive environment for Viscount’s top line revenues for 2013 and 2014.”
Viscount designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company’s products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
For more information on Viscount, visit www.viscount.com
Although great strides have been made in the prevention and treatment of cervical cancer, there are still over 12,000 newly diagnosed cases in the U.S. every year. In addition, approximately ½ million patients every year are diagnosed with high grade cervical intraepithelial neoplasia (CIN 2/3), the predecessor condition to cervical cancer. Cervical cancer is associated with Human Papilloma Virus, a very common virus that can affect the cells of the cervix. About 57% of cervical cancer is the result of infection by Human Papilloma Virus strain 16 (HPV-16). In 2009, the CDC reported that about 45% of women aged 20 to 24 had HPV. HPV causes a number of other types of cancer as well. In developing countries around the world, the situation is even worse. In India, for example, over 72,000 women died of cervical cancer in 2008.
Advaxis is a biotechnology company developing therapeutic immunotherapies targeting HPV-associated diseases: cervical intraepithelial neoplasia (CIN 2/3), recurrent or refractory cervical cancer, as well as head and neck cancer. They have also developed immunotherapies for prostate cancer and HER2 expressing cancers (such as breast, gastric, bladder, brain, pancreatic, ovarian cancer, and canine osteosarcoma).
Advaxis immunotherapies are based on a unique platform technology that uses live, attenuated bacteria, bio-engineered to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to the cancer itself. The company currently has more than fifteen constructs in various stages of development, either developed directly by Advaxis or through strategic collaborations with recognized centers of excellence, such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, and the University of Pennsylvania, among others. ADXS-HPV, the company’s first construct, is being evaluated in 4 Phase 2 clinical trials for HPV associated diseases (CIN 2/3, cervical cancer, and head and neck cancer).
For additional information, visit www.Advaxis.com
MEDL Mobile, a developer, acquirer, and publisher of mobile apps, has teamed up with EUE/Sokolow and producer Damon Harman to act on their vision of turning the company’s popular App Incubator platform into a television show.
The App Incubator allows persons with an idea for an app to submit their concept to get the ball rolling for possible development. Since the program’s launch in 2009, MEDL Mobile has received more than 125,000 app submissions and has developed dozens of apps from the Incubator, and some submitted ideas have achieved top recognition, ranked at No. 1 on the Apple App Store.
Such success has motivated the company to move forward with its own idea of launching a show based on the mobile technology with a primary focus on the idealists themselves.
“Demand for our App Incubator continues to be strong with new ideas coming in every day,” Dave Swartz, MEDL Mobile president and CEO stated in the press release. “But what’s more fascinating than the ideas themselves are the people behind them. Television is the perfect medium to bring the Incubator to life in a big way.”
The Incubator and the apps it has created have garnered attention by several mainstream media outlets, including CNBC, ABC, FOX, The Guardian, The Washington Post, The LA Times, Forbes, CNN, and The BBC.
“With the popularity of shows like Shark Tank, we’ve seen that viewers want to see shows with real stakes, including the American Dream of launching your own business or product,” said Sam Sokolow, president of EUE/Sokolow. “The App Incubator TV Show is a high stakes competition but it’s also a great platform for telling meaningful stories, experiencing people’s digital dreams and organically building online and mobile communities through the apps the show launches. The show will be a home run on so many levels.”
The show will feature contestants working with a panel of technology “Luminaries,” who will chip away to narrow the field until one app is chosen for production each week. A panel of technology Luminaries is now being cast and MEDL Mobile said that it plans to present the show to potential network partners in the first quarter of 2013.
For more information visit www.medlmobile.com
Synthesis Energy reported entry today into an agreement with an undisclosed U.S.-based firm aimed at determining the best strategies for implementing the company’s own proprietary gasification technology, U-GAS®, for producing so-called ‘green’ chemicals from waste and landfill feedstocks. The financial and technical data developed in the study will help determine plant guidelines for up-scaled processing requirements.
Synthesis will have some help from globally recognized construction, engineering, and procurement firm Fluor Enterprises in leading this engineering study, and the company will be looking hard for a perfectly tuned combination of waste feedstocks. The source material once again gives SYMX the chance to showcase how robust their gasification technology is. Designed principally as a silver bullet for cleanly harnessing the maximum potential of low-grade coal seams, the technology is also able to process a wide range of feedstocks in a highly efficient and environmentally friendly manner.
The company will be looking at a variety of inputs here from used tires to auto-shredder residues and other refuse-derived fuels, taking the materials through to production of commercially viable methanol products. The necessary, associated processing infrastructure on the drawing board should win extremely high marks in the environmental sustainability area, as in all we are looking at a very clean system here, taking chemically hazardous waste that would otherwise impact the environment and performing the conversion to methanol via an exceptionally low emissions profile. Add to this fact the proposed facilities would be able to do nearly complete carbon capture and we are talking a reciprocal value bonanza.
The study being commissioned is largely shielded in certain respect due to a confidentiality agreement on the one hand and the highly competitive nature of the cleantech sector on the other. As it would be unwise to divulge further details about the deal, or the un-named U.S.-based company behind the study’s commissioning, SYMX will be dropping more information on such details towards end point targets in the (anticipated as being) four month study. Post completion of the study, SYMX will be looking to further the relationship with this important potential partner and advance to the next logical steps of the overall process.
President and CEO of SYMX, Robert Rigdon, commenting on the versatility of the company’s gasification technology, described how it would allow for an exceptionally clean use of the waste and landfill materials in question, producing high-value end products while helping to green the environment. Rigdon went on to extol how such technology can help us drastically reduce the overall carbon footprint associated with so many of the chemical products that we use on a daily basis.
Rigdon pledged to work hand-in-hand with Fluor to produce a real shining example of the in-house technical expertise in this field possessed by SYMX. Rigdon clearly mapped out how success in the study should lead to a quite lucrative relationship, a relationship which will form the basis of a “technology, equipment, and services supply business” to meet this rapidly growing demand from industry in general.
We will be listening for good news from U-GAS developer SYMX as the study advances over the next four months, but investors can already take a closer look at the technology and at this winning cleantech developer by visiting the following website: www.SynthesisEnergy.com.
Today's Top 3
Global Investment Alert
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Present at the 6th Annual OneMedForum
- Bergamo Acquisition Corp. (BGMO) Signs Investment Agreement
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Launching Sales Campaign With Public Safety Market Leader Tiburon
- International Stem Cell Corp. (ISCO) Announces Positive Animal Efficacy Results in Liver Disease Program
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for Year Ended December, 31 2012
- TNI BioTech Inc. (TNIB) Acquires the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists for the Treatment of Inflammatory and Ulcerative Diseases of the Bowel
- Viaspace, Inc. (VSPC) Giant King Grass Energy Crop Growing in Hawaii
- Viscount Systems, Inc. (VSYS) To Secure Canadian Hotel Chain
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium